Physician profile
Peter Borden
NPI 1972527380
$111,318.83
in general payments reported to CMS, 2019-2025
19 companies · $52K in 2025
The $52K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,568 · 2020: $3,385 · 2021: $8,112 · 2022: $14K · 2023: $8,712 · 2024: $19K · 2025: $52K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $66K · Consulting Fee: $9,125 · Travel and Lodging: $2,206 · Food and Beverage: $1,261 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $66,354.19 |
| Consulting Fee | $9,125.00 |
| Travel and Lodging | $2,205.82 |
| Food and Beverage | $1,260.71 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $100,890.08 | 2019-2025 | Arthrex |
| Zimmer Biomet Holdings, INC. | $4,730.84 | 2019-2020 | |
| Micromed INC | $3,886.23 | 2019-2021 | |
| Saxum Surgical, INC. | $612.30 | 2022-2024 | |
| Goode Surgical INC | $249.02 | 2023 | |
| Stryker Corporation | $246.95 | 2021-2024 | Gamma |
| Dynasplint Systems INC. | $191.67 | 2021 | |
| Bioventus LLC | $123.04 | 2021-2025 | Exogen Ultrasound Bone Healing System, Supartz Fx Sodium Hyaluronate, Gelsyn-3 |
| Pacira Pharmaceuticals Incorporated | $88.20 | 2023-2025 | Exparel, Iovera, Zilretta |
| Depuy Synthes Sales INC. | $76.36 | 2019-2023 | Orthovisc |
| Smith+Nephew, INC. | $45.80 | 2022 | |
| Orthofix Medical, INC. | $31.09 | 2025 | Physio-Stim |
| Horizon Therapeutics Plc | $27.59 | 2019 | |
| Integra Lifesciences Corporation | $24.08 | 2019 | |
| Linvatec Corporation | $23.10 | 2023 | Biobrace 23mm |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $20.26 | 2020 | |
| Fidia Pharma USA INC. | $18.52 | 2019 | |
| Axogen | $17.00 | 2019 | |
| Galderma Laboratories, L.P. | $16.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Borden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.